Herschbach Peter, Berg Petra, Dankert Andrea, Duran Gabriele, Engst-Hastreiter Ursula, Waadt Sabine, Keller Monika, Ukat Robert, Henrich Gerhard
Institute and Outpatient Clinic for Psychosomatic Medicine, Psychotherapy und Medical Psychology, Technical University of Munich, Munich, Germany.
J Psychosom Res. 2005 Jun;58(6):505-11. doi: 10.1016/j.jpsychores.2005.02.007.
The aim of this study was the development and psychometric testing of a new psychological questionnaire to measure the fear of progression (FoP) in chronically ill patients (cancer, diabetes mellitus and rheumatic diseases).
The Fear of Progression Questionnaire (FoP-Q) was developed in four phases: (1) generation of items (65 interviews); (2) reduction of items--the initial version of the questionnaire (87 items) was presented to 411 patients, to construct subscales and test the reliability; (3) testing the convergent and discriminative validity of the reduced test version (43 items) within a new sample (n=439); (4) translation--German to English.
The scale comprised five factors (Cronbach's alpha >.70): affective reactions (13 items), partnership/family (7), occupation (7), loss of autonomy (7) and coping with anxiety (9). The test-retest reliability coefficients varied between .77 and .94. There was only a medium relationship to traditional anxiety scales. This is an indication of the independence of the FoP. Significant relationships between the FoP-Q and the patient's illness behaviour indicate discriminative validity.
The FoP-Q is a new and unique questionnaire developed for the chronically ill. A major problem and source of stress for this patient group has been measuring both specifically and economically the FoP of an illness. The FoP-Q was designed to resolve this problem, fulfill this need and reduce this stress.
本研究旨在开发并进行心理测量测试一种新的心理问卷,以测量慢性病患者(癌症、糖尿病和风湿性疾病)的疾病进展恐惧(FoP)。
疾病进展恐惧问卷(FoP-Q)分四个阶段开发:(1)项目生成(65次访谈);(2)项目缩减——问卷初始版本(87个项目)呈现给411名患者,以构建子量表并测试信度;(3)在一个新样本(n = 439)中测试缩减版测试(43个项目)的收敛效度和区分效度;(4)翻译——从德语到英语。
该量表包含五个因子(克朗巴赫α系数>.70):情感反应(13个项目)、伴侣关系/家庭(7个)、职业(7个)、自主性丧失(7个)和应对焦虑(9个)。重测信度系数在.77至.94之间。与传统焦虑量表只有中等程度的相关性。这表明疾病进展恐惧的独立性。疾病进展恐惧问卷与患者疾病行为之间的显著关系表明了区分效度。
疾病进展恐惧问卷是为慢性病患者开发的一种全新且独特的问卷。该患者群体的一个主要问题和压力来源一直是如何既具体又经济地测量疾病进展恐惧。疾病进展恐惧问卷旨在解决这一问题,满足这一需求并减轻这种压力。